View multimedia release here. Rye Brook, N.Y. (Aug. 7, 2018) — As costs for cancer care skyrocket – projected to be $173 billion by 2020, a 39 percent increase from 2010 – The Leukemia & Lymphoma Society® (LLS) is renewing its call for action to ease the cost of cancer care for patients. Today, LLS released a national “Progress Report on the Cost of Cancer Care,” a review of policy measures tak...
Rye Brook, N.Y. (July 20, 2018) – Progress in treating acute myeloid leukemia (AML), a blood cancer that takes more than 10,000 lives in the United States each year, took an important step forward today with the U.S. Food & Drug Administration (FDA) approval of ivosidenib (Tibsovo®) for patients who have a specific genetic mutation called IDH1. The Leukemia & Lymphoma Society (LLS), a leader i...
(Rye Brook, NY, July 10, 2018) - The Leukemia & Lymphoma Society (LLS) announced today five new appointments to its board of directors, including four influential research scientists; Casey Cunningham, M.D., Christopher Flowers, M.D., Janice L. Gabrilove, M.D. and Ruben A. Mesa, M.D. Their appointments build strength in the diagnosis and treatment of lymphoma and myeloproliferative neoplasms as well as methods fo...
View multimedia release here. Rye Brook, NY (July 9, 2018) – In a spirited philanthropic competition to raise the most money for cancer cures in a 10-week timeframe, dedicated community leaders and their teams of supporters in cities across the country volunteered their time, skills, energy and passion to compete for the prestigious national title of The Leukemia & Lymphoma Society’s (LLS) Man & W...
(Rye Brook, NY, June 12, 2018) – Despite the many advances in cancer treatments and survival rates, many patients still are living with cancer and experiencing the darkness that can come with it. That’s why The Leukemia & Lymphoma Society (LLS) conceived Random Acts of Light Day, in conjunction with its flagship fundraising campaign – Light The Night (LTN) (www.LightTheNight.org) – a series of 140 inspiri...
Rye Brook, NY – June 11, 2018 – The U.S. Food and Drug Administration (FDA) decision to expand the approval of a targeted therapy for patients with chronic lymphocytic leukemia (CLL) and small lymphocytic leukemia (SLL) is a significant development in the treatment of these patients, according to The Leukemia & Lymphoma Society® (LLS). The FDA approved venetoclax (Venclexta®...
(Rye Brook, NY, June 7, 2018) – For the second year in a row, high school students across the country are redefining what it means to be philanthropic in today’s youth culture. Through The Leukemia & Lymphoma Society’s (LLS) newest innovation in fundraising, Students of the Year, more than 600 motivated high school students raised significant funds for LLS’s cutting-edge cancer research and ...
Camden, NJ (June 1, 2018) – Everyone loves a three-peat, especially when the winning combination helps provide care and support to people fighting cancer. For the third consecutive year, Subaru of America, Inc. and The Leukemia & Lymphoma Society (LLS) will spread love, hope and warmth to cancer patients and their families in communities across the country. Over the past two years, Subaru Loves to Care, the...
Have media inquiries? Contact us between 9 a.m. and 5 p.m. ET, Monday through Friday: